Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

In order to ensure a maximum commercial return on the company's highly promising late-stage pipeline, Lundbeck is setting up a new unit dedicated to completing the development and marketing of Lundbeck's new pharmaceuticals. H. Lundbeck A/S is intensifying its efforts to bring the company's new pharmaceuticals to market. Setting up a whole new unit, New Products, as of today, Lundbeck dedicates even more resources to the strategically important task of developing and commercialising the company's promising late-stage products.

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address